GENERAL ORTHOPAEDICS
Single bupivacaine administration for pain reduction after iliac crest bone graft harvest
Orthopedics. 2014 May 1;37(5):e428-34. doi: 10.3928/01477447-20140430-52.40 patients undergoing posterior spinal fusion with posterior iliac crest bone graft were randomized to receive either a single administration of bupivacaine or placebo at the donor site. The purpose of this study was to evaluate long-term pain management between the two groups. Results at 20 weeks indicated significantly lower pain (visual analogue scale; VAS) at rest scores in favour of patients treated with bupivacaine over placebo. Numeric rating scale (NRS) scores for worst, average, and current pain were comparable between groups at 20 weeks. Health quality and functional outcomes were similar between groups. Patient satisfaction was higher in the bupivacaine group, although statistical significance was not reached.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
